Robert John Mowry, MD in Dexter, MI - Otolaryngology

Robert John Mowry, MD is a Otolaryngology physician based in Dexter, Michigan. Robert John Mowry is licensed to practice in Michigan (license number RM071538) and his current practice location is 6967 Wilson Dr, Dexter, Michigan. He can be reached at his office (for appointments etc.) via phone at (517) 250-1502.

NPI number for Robert John Mowry is 1114967445 and his current mailing address is 6967 Wilson Dr, Dexter, Michigan. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1114967445.

Contact Information

	Robert John Mowry, MD
	6967 Wilson Dr, Dexter, MI 48130-9257
	(517) 250-1502
	Not Available

Physician's Profile

Full Name	Robert John Mowry
Gender	Male
Speciality	Otolaryngology
Location	6967 Wilson Dr, Dexter, Michigan
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1114967445
Provider Enumeration Date: 06/07/2006
Last Update Date: 01/28/2013

Medical Identifiers

Medical identifiers for Robert John Mowry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114967445	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	RM071538 (Michigan)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert John Mowry is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert John Mowry, MD 6967 Wilson Dr, Dexter, MI 48130-9257 Ph: (517) 250-1502	Robert John Mowry, MD 6967 Wilson Dr, Dexter, MI 48130-9257 Ph: (517) 250-1502

News Archive

Breakthrough drug significantly delays onset of type 1 diabetes, study finds

Emily Sims, M.D. today shared new findings that a breakthrough drug significantly delays the onset of type 1 diabetes (T1D).

INADA introduces new Sogno DreamWave Spa Massage Chair

World-leading distributor of massage chairs INADA, announced today its new Sogno DreamWave Spa Massage Chair in partnership with European Touch, the leading manufacturer of whirlpool pedicure spas.

Research misconduct allegations shadow likely CDC appointee

A more than 20-year-old controversy over shoddy HIV research is re-emerging as a significant criticism of President Donald Trump's likely pick to lead the Centers for Disease Control and Prevention.

Grant Thornton Leader & Innovator of the Year award for Diplomat Specialty Pharmacy president

Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy in Flint, has been named Grant Thornton Leader & Innovator of the Year.

New collaboration may allow researchers to develop potential gene therapies for pediatric diseases

A new collaboration between Seattle Children's Research Institute and bluebird bio, Inc., a biotechnology company based in Cambridge, Mass. and Seattle, will allow researchers to develop potentially transformative gene therapies for severe genetic and rare pediatric diseases. The collaboration supports pediatric researchers in Seattle who will work with bluebird bio scientists and the company's gene editing technology to research potential cures for genetic pediatric diseases.

Robert John Mowry, MD - Otolaryngology in Dexter, MI